Safety and Performance of a New Coating for Urinary Intermittent Catheters
Not Applicable
Completed
- Conditions
- Intermittent Urethral Catheterization
- Registration Number
- NCT01800903
- Lead Sponsor
- Coloplast A/S
- Brief Summary
The aim of the study is to evaluate safety and performance of a new catheter coating,compared to the current SpeediCath coating.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
- Have given written informed consent and signed letter of authority
- Be at least 18 years of age and have full legal capacity
- Be a male
- Willing to refrain from using analgetics up to 24 hours prior to catheterization visits
Exclusion Criteria
- Abnormalities, diseases or surgical procedures performed in the lower urinary tract
- Symptoms of urinary tract infections (at least one of the following: frequent urination, stinging or pain at urination)
- Participating in other interventional clinical investigations during this investigation (inclusion to termination) or have previously participated in this investigation (including run-in period)
- Known hypersensitivity toward any of the test products -
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Overall Discomfort During Catheterization 1 day Evaluated by the subject on a 10 cm Visual Analog Scale (VAS), where 0 cm is no discomfort and 10 cm is the worst possible discomfort.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the improved safety of ZN-C and ZN-D catheter coatings compared to SpeediCath in urinary intermittent catheterization?
How does the new catheter coating in NCT01800903 compare to standard-of-care in reducing urethral trauma and infection rates?
Are there specific biomarkers associated with enhanced urothelial protection from novel catheter coatings in intermittent self-catheterization?
What adverse events are reported with ZN-C and ZN-D catheters versus SpeediCath in healthy volunteers undergoing urinary catheterization?
What competitor devices or alternative coatings are being evaluated for urinary intermittent catheterization in clinical trials?
Trial Locations
- Locations (1)
Department of Urology
🇩🇰Copenhagen, Denmark
Department of Urology🇩🇰Copenhagen, Denmark